Document Detail

DNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell lines.
MedLine Citation:
PMID:  24817947     Owner:  NLM     Status:  In-Data-Review    
Gemcitabine is a potential chemotherapy drug for treatment of head and neck squamous cell carcinoma (HNSCC), however, the poor or partial response of HNSCC patients to gemcitabine demonstrated the urgent need for gemcitabine biomarkers to improve the therapy. In present work, 10 HNSCC cell lines were employed to figure out the biomarkers for gemcitabine sensitivity. The sensitivities of these 10 cell lines to gemcitabine and the basal expression of these cell lines was investigated, the correlation between gemcitabine response (IC50 dose) and gene expression was investigated by Pearson correlation and FDR estimation. The top seven positive genes responsible for gemcitabine sensitivity were validated by qPCR in these 10 HNSCC cell lines, while only two genes (SBF1 and ZNF195) were expression-correlated to gemcitabine response. Furthermore, ZNF195 expression was closely associated with gemcitabine sensitivity in the subsequent independent validation in cell lines from various types of cancer. Our work might provide potential biomarkers for gemcitabine sensitivity in HNSCC and various type of cancer.
Min-Hui Zhu; Shun-Long Ji; Cai-Yun Zhang; Long Cui; Lei Xiong; Hong-Liang Zheng
Related Documents :
24498137 - Elevated mir-222-3p promotes proliferation and invasion of endometrial carcinoma via ta...
25036647 - Cell uptake and localization studies of squaramide based fluorescent probes.
24374147 - Key roles for grb2-associated-binding protein 1, phosphatidylinositol-3-kinase, cycloox...
24954407 - A mammary repopulating cell population characterized in mammary anlagen reveals essenti...
1793807 - A metabolically competent human cell line expressing five cdnas encoding procarcinogen-...
22229797 - Production of nuclear transfer embryos by using somatic cells isolated from milk in buf...
Publication Detail:
Type:  Journal Article     Date:  2014-03-15
Journal Detail:
Title:  International journal of clinical and experimental pathology     Volume:  7     ISSN:  1936-2625     ISO Abbreviation:  Int J Clin Exp Pathol     Publication Date:  2014  
Date Detail:
Created Date:  2014-05-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101480565     Medline TA:  Int J Clin Exp Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1514-23     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.
Next Document:  RNA-seq reveals determinants of sensitivity to chemotherapy drugs in esophageal carcinoma cells.